Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index

Clinical trial NCT07428681 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07428681
Sponsor: University Hospital, Basel, Switzerland
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Delirium Confusional State

Start date: 2027-03-01
Primary completion: 2028-02-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.